Skip to content

Clinical trials

Completed Bronchial Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchial Diseases Status: Completed Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20121
20132
20145
20152
20164
20172
20181
20191
20222
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca14
Novartis Pharmaceuticals2
Albert Einstein College of Medicine1
Brigham and Women's Hospital1
Columbia University1
DARTNet Institute1
David Van Sickle1
Hill-Rom1
Mayo Clinic1
National Heart, Lung, and Blood Institute (NHLBI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchial Diseases26
Lung Diseases23
Asthma21
Lung Diseases, Obstructive21
Respiratory Tract Diseases21
Immune System Diseases6
Respiratory Hypersensitivity6
Hypersensitivity4
Hypersensitivity, Immediate4
Pulmonary Disease, Chronic Obstructive3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.